SCHEMBL20022719

SCHEMBL20022719

O=c1[nH]sc2c(C(F)(F)F)cccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.48
▸ MAPT P10636 4/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ LMNA P02545 3/20 0.48
▸ HTT P42858 2/20 0.48
▸ CACNA1B Q00975 2/20 0.48
▸ APBA1 Q02410 2/20 0.48
▸ DDAH1 O94760 1/20 0.48
▸ CASP3 P42574 1/20 0.48
▸ PARP1 P09874 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ POLB P06746 2/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ MAPK1 P28482 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ KIF11 P52732 1/20 0.39
▸ CES1 P23141 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1412268 0.76 ALDH1A1 (0.48) KDM4EMAPTALDH1A1LMNAHTT
SCHEMBL9455748 0.73 ALDH1A1 (0.50) KDM4EMAPTALDH1A1LMNAHTT
SCHEMBL6232605 0.72 ALDH1A1 (0.48) KDM4EMAPTALDH1A1LMNAHTT
SCHEMBL20022717 0.72 KDM4E (0.48) KDM4EMAPTALDH1A1LMNAHTT
SCHEMBL25871160 0.70 HDAC3 (0.43) KDM4EALDH1A1LMNAHTTPARP1
SCHEMBL292306 0.68 ALDH1A1 (0.41) KDM4EMAPTALDH1A1LMNAHTT
SCHEMBL26476547 0.68 KDM4E (0.47) KDM4EALDH1A1LMNAHTTPARP1
SCHEMBL31288017 0.68 CA1 (0.44) KDM4EMAPTALDH1A1LMNAHTT
SCHEMBL4213640 0.66 PARP1 (0.65) KDM4EMAPTPARP1SMN1; SMN2HSD17B10
SCHEMBL26078 0.66 ALDH1A1 (1.00) KDM4EMAPTALDH1A1LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180092908-A1 SMALL MOLECULE OXIDIZERS OF PDI AND THEIR USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2018-04-05 — — US disclosed
US-20180092908-A1 SMALL MOLECULE OXIDIZERS OF PDI AND THEIR USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2018-04-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180092908-A1 SMALL MOLECULE OXIDIZERS OF PDI AND THEIR USE PDIA5, PDIA4, PDIA6 KDM4E 4750/4885MAPT 183/4885ALDH1A1 1489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback